Table 5.
Baseline diagnosis of patients whose PFS was significantly prolonged compared to their previous PFS.
| n | Baseline diagnosis | |
|---|---|---|
| DAC | 2 | Hepatocellular carcinoma |
| Esophageal adenocarcinoma | ||
|
| ||
| DAC + chemo | 10 | Hodgkin's lymphoma (3) |
| Respiratory tract cancer (2) | ||
| Lung adenocarcinoma (2) | ||
| Urogenital neoplasms (3) | ||
|
| ||
| DAC + CIK | 3 | Pancreatic cancer |
| Hepatocellular carcinoma (2) | ||
Note. CIK: cytokine induced killer cells; DAC + chemo: decitabine in combination with chemotherapy; DAC + CIK: decitabine in combination with CIK. P value < 0.05 was considered significant.